10
Participants
Start Date
May 1, 2017
Primary Completion Date
June 18, 2018
Study Completion Date
June 18, 2018
Dalbavancin via Intravenous Administration
Patients will undergo plasma fluid pharmacokinetic sampling for determination of dalbavancin concentrations at time zero, 1 hour, 2 hours, 3 hours, 4 hours, 6 hours, at time of volume exchange.
Dalbavancin via Intraperitoneal Administration
Patients will undergo peritoneal fluid pharmacokinetic sampling for determination of dalbavancin concentrations at time zero, 1 hour, 2 hours, 3 hours, 4 hours, 6 hours, at time of volume exchange.
University of Colorado Hospital, Aurora
University of Colorado, Denver
OTHER